Previous 10 |
home / stock / mrntf / mrntf news
The MEDICREA ® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD ® ASI (Adaptive Spine Inte...
Significant Improvement in Gross Margin Up 7 Points at 78% Positive Ebitda (1) Tight Control Over Operating Expense Reduction of Operating Loss The Medicrea Group (Euronext Growth Paris: FR0004178572-ALMED ; OTCQX Best Market –MRNTF), pioneering the transf...
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market – MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD ASI™ (Adaptive Spine Intel...
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED; OTCQX Best Market – MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD ASI™ (Adaptive Spine Intell...
STRONG GROWTH IN UNID® PATIENT-SPECIFIC SURGERIES IN THE USA: +68% WW SALES INCREASED BY 10% IN Q1 (+6% at constant exchange rate) USA SALES INCREASED BY 15% IN Q1 (+8% at constant exchange rate) STRENGTHENING OF MEDICREA PRODUCTS PORTFOLIO WITH PENDING FDA APPROVAL FOR A ...
2018 Annual Sales: € 32.3M, +22% at Constant Exchange Rate Strong Growth of UNiD® Surgeries in the USA: +67% Gross Margin Jumping to 77% in the 4 th Quarter EBITDA at Break-Even in H2 2018 Positive EBITDA Expected for 2019 A Unique Model in Patient-Specific Spi...
News, Short Squeeze, Breakout and More Instantly...
Medicrea International Company Name:
MRNTF Stock Symbol:
OTCMKTS Market:
Medtronic Completes Acquisition of Medicrea Canada NewsWire DUBLIN, Nov. 16, 2020 Acquisition Expands Medtronic's Artificial Intelligence and Data Capabilities, Becoming the First Company to Offer an Integrated Spine Solution Including AI-Driven Surgical Planning, ...
Q3 Sales Growth: +4% in the USA and +11% in France vs Q3 2019 Strong Demand in UNiD® Activity in the USA for September: +49% vs 2019 6,450 UNiD™ Personalized Surgeries Performed on a Cumulatve Basis as of September 30, 2020 The MEDICREA® ...
EBITDA (1) : €1,9M POSITIVE LIMITED OPERATING LOSS DESPITE COVID-19 CRISIS STEPS TO MERGE WITH MEDTRONIC IN PROGRESS The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of...